Monocyte Gene and Molecular Expression Profiles Suggest Distinct Effector and Regulatory Functions in Beninese HIV Highly Exposed Seronegative Female Commercial Sex Workers.
Adult
Antiviral Restriction Factors
/ genetics
Benin
/ epidemiology
Dendritic Cells
/ immunology
Disease Resistance
/ immunology
Female
Flow Cytometry
Gene Expression Profiling
HIV Infections
/ immunology
HIV Seronegativity
/ immunology
HIV-1
/ immunology
Humans
Middle Aged
Monocytes
/ immunology
Sex Workers
/ statistics & numerical data
HIV
commercial sex workers
effector functions
highly exposed seronegative (HESN)
monocytes
regulatory functions
resistance
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
10 02 2022
10 02 2022
Historique:
received:
16
12
2021
revised:
04
02
2022
accepted:
06
02
2022
entrez:
26
2
2022
pubmed:
27
2
2022
medline:
17
3
2022
Statut:
epublish
Résumé
We have previously reported that the female genital tract (FGT) of Beninese HIV highly-exposed seronegative (HESN) commercial sex workers (CSWs), presented elevated frequencies of a myeloid HLA-DR+CD14+CD11c+ population presenting "tolerogenic" monocyte derived dendritic cells (MoDC) features. In order to assess whether a differential profile of monocytes may be involved in the generation of these genital MoDCs, we have herein characterized the blood monocyte compartment of Beninese HESNs (HIV-uninfected ≥ 10 years CSWs) and relevant controls (HIV-uninfected 2.5-5 years CSWs herein termed "early HESNs"), HIV-infected CSWs, and low-risk HIV-uninfected women from the general population. Transcriptomic analyses by RNA-Seq of total sorted blood monocytes demonstrate that in comparison to the control groups, HESNs present increased expression levels of FCGR2C, FCAR, ITGAX, ITGAM, CR2, CD68, and CD163 genes, associated with effector functions. Moreover, we found increased expression levels of genes associated with protection/control against SHIV/HIV such as CCL3, CCL4, CCL5, BHLHE40, and TNFSF13, as well as with immune regulation such as IL-10, Ahr, CD83, and the orphan nuclear receptor (NR)4A1, NR4A2, and NR4A3. Through multicolor flow cytometry analyses, we noticed that the frequencies of intermediate and non-classical monocyte populations tended to be elevated in the blood of HESNs, and exhibited increased expression levels of effector CD16, CD11c, CD11b, as well as regulatory HLA-G, IL-10, and IFN-α markers when compared to HIV-uninfected women and/or HIV-infected CSWs. This profile is compatible with that previously reported in the FGT of HESNs, and likely confers an enormous advantage in their resistance to HIV infection.
Identifiants
pubmed: 35215954
pii: v14020361
doi: 10.3390/v14020361
pmc: PMC8878004
pii:
doi:
Substances chimiques
Antiviral Restriction Factors
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Science. 2015 Aug 14;349(6249):aab1253
pubmed: 26229114
Nat Immunol. 2011 Jul 03;12(8):778-85
pubmed: 21725321
Cell Mol Biol Lett. 2020 Nov 3;25(1):48
pubmed: 33292165
Immunity. 2016 May 17;44(5):1052-68
pubmed: 27192569
Mucosal Immunol. 2016 Nov;9(6):1549-1558
pubmed: 26960182
PLoS Pathog. 2019 Jun 7;15(6):e1007840
pubmed: 31173604
Front Immunol. 2018 Aug 03;9:1797
pubmed: 30123220
Transplant Res. 2012 Sep 28;1(1):14
pubmed: 23369527
Sci Transl Med. 2019 Sep 18;11(510):
pubmed: 31534016
Front Med (Lausanne). 2020 Jul 17;7:299
pubmed: 32850873
Blood. 2010 Aug 12;116(6):935-44
pubmed: 20448110
Sci Rep. 2017 Mar 06;7:43857
pubmed: 28262752
Front Microbiol. 2018 Jun 20;9:1326
pubmed: 29973924
Front Immunol. 2019 Feb 28;10:332
pubmed: 30873178
J Med Dent Sci. 2006 Jun;53(2):85-91
pubmed: 16913569
Genes Immun. 2019 Nov;20(8):651-659
pubmed: 30563969
Front Immunol. 2018 Aug 13;9:1869
pubmed: 30150991
Front Immunol. 2019 Aug 30;10:2035
pubmed: 31543877
J Steroid Biochem Mol Biol. 2016 Mar;157:48-60
pubmed: 25917081
Mucosal Immunol. 2008 Jul;1(4):309-16
pubmed: 19079192
J Virol. 2008 Dec;82(24):12449-63
pubmed: 18842730
Blood Adv. 2018 Nov 13;2(21):2862-2878
pubmed: 30381402
J Infect Dis. 2009 May 1;199(9):1318-22
pubmed: 19301980
Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15150-15159
pubmed: 31285338
Annu Rev Med. 2015;66:423-37
pubmed: 25341006
J Immunol. 2001 May 1;166(9):5530-9
pubmed: 11313392
Viruses. 2018 Feb 06;10(2):
pubmed: 29415518
Immunol Rev. 2020 Jan;293(1):8-24
pubmed: 31840836
Leukemia. 2019 Jan;33(1):52-63
pubmed: 29884904
Front Immunol. 2020 Jun 09;11:1141
pubmed: 32582208
Immunity. 2017 May 16;46(5):764-766
pubmed: 28514680
J Clin Immunol. 2010 Jan;30(1):90-8
pubmed: 19898927
Viruses. 2018 Apr 23;10(4):
pubmed: 29690575
Front Immunol. 2017 Nov 20;8:1590
pubmed: 29209323
J Clin Invest. 2014 Sep;124(9):3879-90
pubmed: 25105367
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
Elife. 2021 Sep 17;10:
pubmed: 34533134
Front Immunol. 2018 Sep 19;9:2033
pubmed: 30283437
J Infect Dis. 2014 Jul 15;210(2):319-29
pubmed: 24421257
J Virol. 2018 Mar 14;92(7):
pubmed: 29321320
Sci Transl Med. 2019 Aug 28;11(507):
pubmed: 31462510
J Exp Med. 2018 Jul 2;215(7):1823-1838
pubmed: 29773644
Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1306-16
pubmed: 25838429
N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
PLoS One. 2020 Sep 1;15(9):e0238347
pubmed: 32870938
Sci Rep. 2016 Sep 27;6:34310
pubmed: 27670158
PLoS One. 2016 Mar 03;11(3):e0150450
pubmed: 26938745
J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):474-84
pubmed: 27003495
PLoS One. 2017 Apr 26;12(4):e0176460
pubmed: 28445506
Nat Immunol. 2013 Mar;14(3):201-3
pubmed: 23416671
Cell. 2013 Apr 11;153(2):362-75
pubmed: 23582326
AIDS Res Hum Retroviruses. 2014 Nov;30(11):1145-9
pubmed: 25354025
Immunity. 2017 May 16;46(5):849-862.e7
pubmed: 28514690
J Exp Med. 2002 Aug 19;196(4):517-27
pubmed: 12186843
Hum Immunol. 2010 Feb;71(2):182-5
pubmed: 19913587
Front Immunol. 2018 Mar 29;9:244
pubmed: 29651286
Antibodies (Basel). 2019 Oct 11;8(4):
pubmed: 31614541